TAKEDA PHARMA A/S: Financial statements 2022
CVR: 16406899
Source: annual report 2022, Danish Business Authority
01/04/2021 – 31/03/2022
TAKEDA PHARMA A/S (CVR 16406899) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 910,058,000 and a net result of DKK 31,795,000 compared with DKK 667,744,000 the year before. That is a decrease of 53.1% compared with the year before. The profit margin was 3.5%. Equity in the 2022 report amounted to DKK 81,238,000. The solvency ratio was 13.1%. The company had 180 employees in the financial year.
- Revenue
- DKK 910,058,000
- Gross Profit
- DKK 153,989,000
- Profit/Loss
- DKK 31,795,000
- Equity
- DKK 81,238,000
- Total Assets
- DKK 622,293,000
- Employees
- 180
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 910.1M | 154M | 31.8M | 81.2M | 180 |
| 2021 | 1.9B | 1.1B | 667.7M | 1B | 174 |
| 2020 | 1.6B | 3.2B | 2.7B | 2.7B | 179 |
| 2019 | 1.6B | 562.3M | 84.7B | 1.3B | 177 |
| 2018 | 1.8B | 712.1M | 595.8M | 100.5B | 197 |
Official annual report
Keep an eye on TAKEDA PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout TAKEDA PHARMA A/S
TAKEDA PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1984. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NYCOMED DANMARK ApS and NYCOMED DANMARK A/S. The management consists of Enor Cerimagic. The board consists of Koki Sato (chair), Enor Cerimagic, Jesper Lindahl and Malene Kelstrup. The company is owned by Takeda Pharmaceuticals International AG. The company has 79 employees (2026). In 2026, the company reported revenue of DKK 1,112,753,000 and a net result of DKK 88,641,000 compared with DKK 12,162,000 the year before. Equity in the 2026 report amounted to DKK 456,501,000.